Dr. Paul Brockman, M.D

NPI: 1902864465
Total Payments
$435.07
2024 Payments
$59.01
Companies
13
Transactions
18
Medicare Patients
2,314
Medicare Billing
$275,022

Payment Breakdown by Category

Food & Beverage$435.07 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $435.07 18 100.0%

Top Paying Companies

Company Total Records Latest Year
Allergan Inc. $146.85 1 $0 (2017)
Merz Pharmaceuticals, LLC $67.45 2 $0 (2024)
ABBVIE INC. $52.93 3 $0 (2024)
Depomed, Inc. $29.67 2 $0 (2017)
GENZYME CORPORATION $23.96 2 $0 (2018)
Ipsen Biopharmaceuticals, Inc $19.95 1 $0 (2017)
Medtronic USA, Inc. $18.55 1 $0 (2019)
SI-BONE, Inc. $15.17 1 $0 (2018)
Genentech USA, Inc. $12.90 1 $0 (2017)
ARBOR PHARMACEUTICALS, INC. $12.63 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $59.01 3 ABBVIE INC. ($36.31)
2023 $16.62 1 AbbVie Inc. ($16.62)
2021 $44.75 1 Merz Pharmaceuticals, LLC ($44.75)
2019 $43.74 3 Medtronic USA, Inc. ($18.55)
2018 $50.82 4 GENZYME CORPORATION ($23.96)
2017 $220.13 6 Allergan Inc. ($146.85)

All Payment Transactions

18 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
08/09/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $20.02 General
Category: BOTOX THERAPEUTIC
05/07/2024 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $22.70 General
Category: Musculoskeletal
03/29/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $16.29 General
Category: BOTOX THERAPEUTIC
05/31/2023 AbbVie Inc. BOTOX (Biological) Food and Beverage In-kind items and services $16.62 General
Category: BOTOX THERAPEUTIC
09/22/2021 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $44.75 General
Category: Musculoskeletal
10/22/2019 Medtronic USA, Inc. SYNCHROMED (Device) Food and Beverage In-kind items and services $18.55 General
Category: Drug Infusion Systems
10/10/2019 ARBOR PHARMACEUTICALS, INC. Horizant (Drug) Food and Beverage In-kind items and services $12.63 General
Category: Sleep
03/22/2019 Flexion Therapeutics, Inc. Zilretta (Drug) Food and Beverage Cash or cash equivalent $12.56 General
Category: Musculoskeletal
12/13/2018 SI-BONE, Inc. iFuse Implant (Device) Food and Beverage Cash or cash equivalent $15.17 General
Category: sacroiliac joint dysfunction
12/04/2018 GENZYME CORPORATION LUMIZYME (Drug), POMPE - DISEASE Food and Beverage In-kind items and services $11.36 General
Category: RARE DISEASE GENETICS
11/14/2018 Daiichi Sankyo Inc. Morphabond ER (Drug) Food and Beverage In-kind items and services $11.69 General
Category: Pain Management
03/20/2018 GENZYME CORPORATION LUMIZYME (Drug), POMPE - DISEASE Food and Beverage In-kind items and services $12.60 General
Category: RARE DISEASE GENETICS
10/18/2017 Ipsen Biopharmaceuticals, Inc Dysport 300 U-1 (Drug) Food and Beverage In-kind items and services $19.95 General
Category: Neurology
09/14/2017 Allergan Inc. BOTOX NEURO REHAB (Drug) Food and Beverage In-kind items and services $146.85 General
Category: NEUROSCIENCE
05/25/2017 Depomed, Inc. Nucynta (Drug) Food and Beverage In-kind items and services $13.32 General
Category: Pain
05/17/2017 Genentech USA, Inc. Food and Beverage In-kind items and services $12.90 General
03/28/2017 SANOFI-AVENTIS U.S. LLC LANTUS (Drug) Food and Beverage In-kind items and services $10.76 General
Category: DIABETES
02/23/2017 Depomed, Inc. Nucynta (Drug), Gralise Food and Beverage In-kind items and services $16.35 General
Category: Pain

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 435 548 $150,938 $47,386
2022 13 608 790 $225,380 $71,871
2021 14 653 892 $258,305 $84,693
2020 15 618 828 $233,482 $71,072
Total Patients
2,314
Total Services
3,058
Medicare Billing
$275,022
Procedure Codes
53

All Medicare Procedures & Services

53 procedure records from CMS Medicare Utilization — Page 2 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
95886 Needle measurement and recording of electrical activity of muscles of arm or leg complete study Office 2021 129 192 $52,224 $15,464 29.6%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 66 88 $26,576 $12,189 45.9%
95910 Nerve transmission studies, 7-8 studies Office 2021 64 68 $41,140 $9,648 23.5%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 54 54 $24,786 $9,089 36.7%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 38 38 $13,870 $5,019 36.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 57 64 $10,880 $4,027 37.0%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 39 39 $9,321 $3,384 36.3%
95909 Nerve transmission studies, 5-6 studies Office 2021 27 28 $12,684 $3,183 25.1%
95911 Nerve transmission studies, 9-10 studies Office 2021 16 16 $11,760 $2,734 23.3%
95908 Nerve transmission studies, 3-4 studies Office 2021 16 16 $5,968 $1,394 23.4%
99202 New patient outpatient visit, total time 15-29 minutes Office 2021 12 12 $1,968 $637.14 32.4%
76882 Partial ultrasound of joint or other non-blood vessel structure of arm or leg Office 2021 12 13 $2,080 $507.36 24.4%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2021 13 75 $1,200 $77.31 6.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 101 180 $41,760 $14,452 34.6%
95886 Needle measurement and recording of electrical activity of muscles of arm or leg complete study Office 2020 128 186 $50,592 $14,007 27.7%
95910 Nerve transmission studies, 7-8 studies Office 2020 48 49 $29,645 $6,916 23.3%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 53 61 $18,422 $6,616 35.9%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 46 46 $16,790 $5,901 35.1%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 33 33 $15,147 $5,251 34.7%
95911 Nerve transmission studies, 9-10 studies Office 2020 26 26 $19,110 $4,653 24.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 48 57 $9,690 $3,320 34.3%
95909 Nerve transmission studies, 5-6 studies Office 2020 27 27 $12,231 $2,772 22.7%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 32 32 $7,648 $2,731 35.7%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 23 25 $2,000 $1,485 74.2%
95908 Nerve transmission studies, 3-4 studies Office 2020 15 15 $5,595 $1,286 23.0%

About Dr. Paul Brockman, M.D

Dr. Paul Brockman, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Wyomissing, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902864465.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Brockman, M.D has received a total of $435.07 in payments from pharmaceutical and medical device companies, with $59.01 received in 2024. These payments were reported across 18 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($435.07).

As a Medicare-enrolled provider, Brockman has provided services to 2,314 Medicare beneficiaries, totaling 3,058 services with total Medicare billing of $275,022. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.

Practice Information

  • Specialty Physical Medicine & Rehabilitation
  • Location Wyomissing, PA
  • Active Since 05/03/2006
  • Last Updated 03/25/2013
  • Taxonomy Code 208100000X
  • Entity Type Individual
  • NPI Number 1902864465

Products in Payments

  • BOTOX NEURO REHAB (Drug) $146.85
  • Xeomin (Biological) $67.45
  • BOTOX (Biological) $52.93
  • Nucynta (Drug) $29.67
  • LUMIZYME (Drug) $23.96
  • Dysport 300 U-1 (Drug) $19.95
  • SYNCHROMED (Device) $18.55
  • iFuse Implant (Device) $15.17
  • Horizant (Drug) $12.63
  • Zilretta (Drug) $12.56
  • Morphabond ER (Drug) $11.69
  • LANTUS (Drug) $10.76

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physical Medicine & Rehabilitation Doctors in Wyomissing